{
  "id": "everyday#screening_cues_fcd6c327",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "6C46.73 N/A N/A 6C45.0 Episode of harmful use of cocaine amfetamines, methamfetamine 6C46.61 D 6C46.0 Episode of harmful use of stimulants, including amfetamines, methamfetamine and methcathinone and methcathinone 6C46.62 M 6C47.0 Episode of harmful use of synthetic cathinones Synthetic cathinones 6C47.5 6C47.60 H 6C47.70 6C47.71 6C47.72 6C47.73 N/A N/A 6C48.0 Episode of harmful use of caffeine 6C49.0 Episode of harmful use of hallucinogens 6C47.61 D 6C4A.0 Episode of harmful use of nicotine 6C4B.0 Episode of harmful use of volatile inhalants 6C47.62 M 6C4C.0 Episode of harmful use of MDMA or related drugs, including MDA Caffeine N/A N/A N/A 6C48.40 N/A N/A N/A N/A 6C4D.0 Episode of harmful use of dissociative drugs, including ketamine and PCP Hallucinogens 6C49.4 6C49.5 6C49.60 6C49.61 N/A N/A N/A N/A 6C4E.0 Episode of harmful use of other specified psychoactive substance Nicotine N/A N/A N/A N/A N/A N/A N/A N/A 6C4F.0 Episode of harmful use of multiple specified psychoactive substances, including medications Volatile inhalants 6C4B.5 6C4B.6 6C4B.70 6C4B.71 N/A N/A 6D72.13 6D84.2 6C4G.0 Episode of harmful use of unknown or unspecified psychoactive substances MDMA or related drugs, 6C4C.5 6C4C.6 6C4C.70 6C4C.71 N/A N/A N/A N/A including MDA Dissociative drugs, 6C4D.4 6C4D.5 6C4D.60 6C4D.61 N/A N/A N/A N/A including ketamine and PCP Essential (required) features Other specified 6C4E.5 6C4E.6 6C4E.70 6C4E.71 6C4E.72 6C4E.73 6D72.12 6D84.Y Multiple specified 6C4F.5 6C4F.6 6C4F.70 6C4F.71 6C4F.72 6C4F.73 N/A N/A Unknown or unspecified 6C4G.5 6C4G.6 6C4G.70 6C4G.71 6C4G.72 6C4G.73 N/A N/A Non-psychoactive N/A N/A N/A N/A N/A N/A N/A N/A • An episode of use of a psychoactive substance that has caused clinically significant damage to a person’s physical health (e.g. bloodborne infection from intravenous self- a H = with hallucinations, D = with delusions, M = with mixed psychotic symptoms administration) or mental health (e.g. substance-induced mood disorder), or has resulted in behaviour leading to harm to the health of others, is required for diagnosis. • Harm to the health of the individual occurs due to one or more of the following: behaviour related to intoxication (see Table 6.15, p. 475); direct or secondary toxic effects on body organs and systems; or a harmful route of administration. • Harm to the health of others includes any form of physical harm, including trauma, or mental disorder that is directly attributable to behaviour due to substance intoxication on the part of the person to whom the diagnosis of episode of harmful psychoactive substance use applies. Diagnostic categories that apply to the various classes of psychoactive substances Diagnostic requirements for disorders due to substance use | Episode of harmful psychoactive substance use",
  "gloss_vi": "6c46.73 n/a n/a 6c45.0 episode of harmful use of cocaine amfetamines, methamfetamine 6c46.61 d 6c46.0 episode of harmful use of stimulants, including amfetamines, methamfetamine and methcathinone and methcathinone 6c46.6...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues"
    ],
    "life_topics": [],
    "advice_section": [
      "sleep_hygiene"
    ],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc 6C46.73 N/A N/A 6C45.0 Episode of harmful use of cocaine amfetamines, methamfetamine 6C46.61 D 6C46.0 Episode of harmful use of stimulants, including amfetamines, methamfetamine and methcathinone and methcathinone 6C46.62 M 6C47.0 Episode of harmful use of synthetic cathinones Synthetic cathinones 6C47.5 6C47.60 H 6C47.70 6C47.71 6C47.72 6C47.73 N/A N/A 6C48.0 Episode of harmful use of caffeine 6C49.0 Episode of harmful use of hallucinogens 6C47.61 D 6C4A.0 Episode of harmful use of nicotine 6C4B.0 Episode of harmful use of volatile inhalants 6C47.62 M 6C4C.0 Episode of harmful use of MDMA or related drugs, including MDA Caffeine N/A N/A N/A 6C48.40 N/A N/A N/A N/A 6C4D.0 Episode of harmful use of dissociative drugs, including ketamine and PCP Hallucinogens 6C49.4 6C49.5 6C49.60 6C49.61 N/A N/A N/A N/A 6C4E.0 Episode of harmful use of other specified psychoactive substance Nicotine N/A N/A N/A N/A N/A N/A N/A N/A 6C4F.0 Episode of harmful use of multiple specified psychoactive substances, including medications Volatile inhalants 6C4B.5 6C4B.6 6C4B.70 6C4B.71 N/A N/A 6D72.13 6D84.2 6C4G.0 Episode of harmful use of unknown or unspecified psychoactive substances MDMA or related drugs, 6C4C.5 6C4C.6 6C4C.70 6C4C.71 N/A N/A N/A N/A including MDA Dissociative drugs, 6C4D.4 6C4D.5 6C4D.60 6C4D.61 N/A N/A N/A N/A including ketamine and PCP Essential (required) features Other specified 6C4E.5 6C4E.6 6C4E.70 6C4E.71 6C4E.72 6C4E.73 6D72.12 6D84.Y Multiple specified 6C4F.5 6C4F.6 6C4F.70 6C4F.71 6C4F.72 6C4F.73 N/A N/A Unknown or unspecified 6C4G.5 6C4G.6 6C4G.70 6C4G.71 6C4G.72 6C4G.73 N/A N/A Non-psychoactive N/A N/A N/A N/A N/A N/A N/A N/A • An episode of use of a psychoactive substance that has caused clinically significant damage to a person’s physical health (e.g. bloodborne infection from intravenous self- a H = with hallucinations, D = with delusions, M = with mixed psychotic symptoms administration) or mental health (e.g. substance-induced mood disorder), or has resulted in behaviour leading to harm to the health of others, is required for diagnosis. • Harm to the health of the individual occurs due to one or more of the following: behaviour related to intoxication (see Table 6.15, p. 475); direct or secondary toxic effects on body organs and systems; or a harmful route of administration. • Harm to the health of others includes any form of physical harm, including trauma, or mental disorder that is directly attributable to behaviour due to substance intoxication on the part of the person to whom the diagnosis of episode of harmful psychoactive substance use applies. Diagnostic categories that apply to the various classes of psychoactive substances Diagnostic requirements for disorders due to substance use | Episode of harmful psychoactive substance use 6c46.73 n/a n/a 6c45.0 episode of harmful use of cocaine amfetamines, methamfetamine 6c46.61 d 6c46.0 episode of harmful use of stimulants, including amfetamines, methamfetamine and methcathinone and methcathinone 6c46.6..."
}